Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. GNK
6. USO
7. AWK
8. ARGX
9. AZN
10. SPCX

Go back to Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
(NASDAQ: CRDL) Delayed: 1.80 --0 (-0%)
Previous Close $1.80    52 Week High $ 
Open $1.73    52 Week Low $ 
Day High $1.94    P/E N/A 
Day Low $1.73    EPS $ 
Volume 2,306,079